Cboe and Citadel‑backed Capital Markets Alliance sues CFTC over single‑stock perpetual futures approval
Cboe Global Markets and Citadel Securities, together with the Healthy Markets Association, filed a federal lawsuit on November 3, 2026 to overturn the Commodity Futures Trading Commission’s approval of perpetual futures on individual U.S. stocks and ETFs. The plaintiffs argue the contracts are security‑based swaps that should be regulated by the SEC, not the CFTC, and seek to vacate the approvals and freeze trading. A judge later denied an emergency restraining order, leaving the case to proceed.
Why it matters
If the court classifies the contracts as swaps, U.S. exchanges such as Coinbase and Bitnomial could be barred from listing them, limiting retail access to these products. Conversely, a CFTC victory would allow U.S. exchanges to launch stock perps, potentially diverting trading volume from Cboe’s options business and from offshore platforms like Hyperliquid.
Key facts
- 1Cboe, Citadel Securities and the Healthy Markets Association filed the lawsuit in New York federal court on November 3, 2026. securities.io
- 2The suit seeks to vacate the CFTC’s approval and to have the contracts classified as security‑based swaps subject to SEC jurisdiction. securities.io
- 3CFTC Chairman Michael S. Selig said the contracts were approved under Commission Regulation 40.3 and could trade on CFTC‑registered exchanges. securities.io
- 4A judge denied an emergency restraining order on the lawsuit, allowing the case to continue. thetradenews.com
- 5Cboe’s shares fell 0.90% after the news of the lawsuit. finance.biggo.com
- 6Hyperliquid’s HYPE token was trading at $86, down 1.3% over 24 hours, after the filing. 247wallst.com
Summary written by AlphAI AI Desk from 13 of 13 sources. Not investment advice. Figures are as stated by the linked sources.